Andrew Cant Selected Research

Andrew Cant Research Topics

Disease

6	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020 - 07/2002
5	Infections 04/2017 - 12/2002
4	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2022 - 03/2011
3	Cytopenia 01/2020 - 12/2013
2	Reinfection 01/2019 - 09/2017
2	Type 1 Hyper-IgM Immunodeficiency Syndrome 01/2019 - 04/2017
2	Eczema 01/2019 - 09/2017
2	Lymphadenopathy 01/2016 - 12/2013
2	Lymphoma (Lymphomas) 01/2016 - 04/2015
2	Autoimmune Lymphoproliferative Syndrome 08/2014 - 12/2013
1	Immune System Diseases (Immune Disorders) 01/2022
1	Pathologic Complete Response 01/2020
1	Tetanus 01/2020
1	Bronchiolitis Obliterans Syndrome 01/2020
1	Asthma (Bronchial Asthma) 11/2019
1	Job Syndrome (Hyper-IgE Syndrome) 01/2019
1	Inflammation (Inflammations) 01/2018
1	Eosinophilia 09/2017
1	Craniosynostoses (Craniosynostosis) 09/2017
1	Bronchiectasis 09/2017
1	Acute-Phase Reaction 09/2017
1	Leukemia 01/2016
1	Hematologic Neoplasms (Hematological Malignancy) 01/2016
1	Lymphopenia (Lymphocytopenia) 01/2016
1	Common Variable Immunodeficiency 04/2015
1	Chronic Mucocutaneous Candidiasis 11/2014
1	Splenomegaly 12/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2013
1	Failure to Thrive 01/2013
1	Primary Immunodeficiency Diseases 04/2011
1	Virus Diseases (Viral Diseases) 12/2010
1	Bacterial Infections (Bacterial Infection) 12/2010
1	Brain Diseases (Brain Disorder) 12/2010
1	Confusion (Bewilderment) 05/2008
1	Anaphylaxis (Anaphylactic Shock) 05/2008
1	Osteopetrosis 08/2007
1	Arthralgia (Joint Pain) 01/2007
1	Urticaria (Hives) 01/2007
1	Cartilage-hair hypoplasia 06/2004
1	Chronic Granulomatous Disease 12/2002

Drug/Important Bio-Agent (IBA)

2	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 04/2015
2	SteroidsIBA 01/2020 - 01/2016
2	VaccinesIBA 01/2020 - 07/2011
2	Sirolimus (Rapamycin)FDA Link 01/2020 - 01/2018
2	Immunoglobulin E (IgE)IBA 01/2019 - 09/2017
2	Busulfan (Busulfex)FDA Link 01/2016 - 04/2011
2	treosulfanIBA 01/2016 - 04/2011
1	Alemtuzumab (Campath)FDA Link 01/2020
1	Pharmaceutical PreparationsIBA 11/2019
1	Interleukin-11 (Interleukin 11)IBA 01/2019
1	Interleukin-27 (Interleukin 27)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Immunoglobulin A (IgA)IBA 01/2016
1	Immunoglobulin G (IgG)IBA 01/2016
1	Immunoglobulin M (IgM)IBA 01/2016
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2016
1	Immunomodulating AgentsIBA 04/2015
1	STAT1 Transcription FactorIBA 11/2014
1	2,6-dinitrotoluene (DNT)IBA 08/2014
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 08/2014
1	Biomarkers (Surrogate Marker)IBA 12/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2013
1	Melphalan (Alkeran)FDA LinkGeneric 04/2011
1	fludarabineIBA 04/2011
1	Biological ProductsIBA 12/2010
1	InterferonsIBA 12/2010
1	Epinephrine (Adrenaline)FDA LinkGeneric 05/2008
1	LigandsIBA 08/2007
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2007

Therapy/Procedure

7	Hematopoietic Stem Cell Transplantation 01/2022 - 03/2011
7	Transplantation 04/2017 - 12/2002
3	Cell Transplantation 01/2022 - 04/2017
2	Stem Cell Transplantation 04/2017 - 07/2002
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 06/2004 - 12/2002
1	Therapeutics 11/2019
1	Precision Medicine 11/2019
1	Emergency Treatment 05/2008